About
Quintessence Biologics develops topical skincare and haircare products powered by growth factors and exosomes derived from human umbilical cord and amniotic membrane tissues. The company's approach centers on harnessing bioactive molecules that signal cellular renewal rather than relying on stem cells themselves. Their proprietary technology extracts these signaling compounds and formulates them into clinical-grade, lyophilized products designed for topical application to support skin and hair health.
The company's product line, QBio, brings regenerative medicine principles to consumer skincare. Their offerings include QBio Elixir for skin rejuvenation and QBio Gro for hair growth and scalp vitality. Products are manufactured in the USA using tissue sourced from healthy, full-term scheduled C-section births, then processed into easy-to-use kits. The formulations aim to work at the cellular level by stimulating the body's natural regeneration and restoration processes rather than masking surface concerns.
Quintessence Biologics reports having served over 100,000 people through their regenerative medicine applications. Their technology is patent-pending, and preclinical data indicates their QBio Elixir formulation boosts extracellular matrix production by 100 percent and cell proliferation by 2x, suggesting measurable effects on skin renewal mechanisms.
Longevity Contribution
- Exosomes and growth factors sourced from human umbilical cord and amniotic membrane tissues rather than synthetic or plant-based alternatives
- Proprietary lyophilized formulation technology that preserves bioactive molecules in stable, shelf-stable form
- Clinical-grade products designed for topical use with preclinical data demonstrating 100% increase in ECM production and 2x cell proliferation
- Patent-pending technology with over a decade of development in stem cell-derived bioactive molecule research